Supply Chain

Eli Lilly (NYSE:LLY) announced today that it plans to boost domestic pharmaceutical production with four new U.S. manufacturing sites. The company’s investment in capital expansion across therapeutic areas in the U.S. now totals more than $50 billion since 2020. Indianopolis-based Eli Lilly says three of the future U.S. sites will focus on manufacturing active pharmaceutical…

Uniphar announced today that it launched three new state-of-the-art facilities to expand its international presence. The company unveiled new facilities in Raleigh, North Carolina, Lelystad, the Netherlands, and Dublin, Ireland. It says the facilities mark its commitment to enhancing logistics and distribution capabilities within the global pharmaceutical and healthcare sectors. Uniphar said the locations position…

GE HealthCare (Nasdaq: GEHC) announced a $138 million investment to expand its contrast media fill/finish manufacturing site in Cork, Ireland. The company plans to expand with a new, state-of-the-art facility on the existing grounds of the Carrigtohill, Cork, site. It anticipates 25 million more patient doses per year of contrast media by the end of…

Nelipak announced today that it received International Sustainability and Carbon Certification (ISCC) Plus for its Derry, Northern Ireland facility. ISCC PLUS is a globally recognized standard tracking recycled and bio-based materials through the supply chain. It verifies that companies meet environmental and social standards. Cranston, Rhode Island-based Nelipak manufactures healthcare packaging solutions and offers complementary…

Aragen announced that it received a $100 million investment to support the expansion of its pharmaceutical outsourcing services. Quadria Capital, an Asian healthcare-focused private equity fund, made the investment. This results in the company acquiring a minority stake in Aragen, primarily through a fresh capital infusion. A small portion comes from the sale of shares…

PharmaEssentia has reaffirmed its commitment to creating access to critical interferon therapies amid a reported global shortage. The Burlington, Massachusetts-based company noted a recent reported shortage of Pegasys (peginterferon alfa-2a), a treatment for hepatitis C and B. With concerns growing over drug shortages for other therapies, the company said its established cGMP manufacturing network and…

An African Union effort to strengthen public health and improve vaccine access in Africa has received a $45 million financing package. The U.S. International Development Finance Corporation, the African Development Bank and the International Finance Corporation (IFC) jointly announced the package for VaxSen, a subsidiary of Senegal’s Institut Pasteur de Dakar (IPD). This agreement underscores…

Reckitt Benckiser Group announced today that it is expanding its U.S. manufacturing footprint by acquiring a 310,000 ft² pharmaceutical site in Wilson, North Carolina. The Slough, U.K.–based company said it will invest £155 million ($200 million) to establish a manufacturing facility in Wilson to produce Mucinex tablets and liquids to meet increased U.S. demand. Reckitt…

Sanofi recently announced that it is investing €40 million in its Lyon Gerland bioproduction site as it seeks to bolster its position in the immunology space. The investment will support production in France of the transplant drug Thymoglubulin, including €25 million toward developing and manufacturing a second-generation version of the drug. The remaining €15 million…

Otsuka Holdings will pay ICU Medical (Nasdaq: ICUI) an upfront payment of $200 million as part of a joint venture to enter the U.S. IV products market, which has been facing hurricane-related shortages this fall. The partnership — which involves  ICU Medical providing commercial services for Otsuka’s Otsuka Pharmaceutical Factory (OPF) subsidiary — also includes…